Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on IP matters related to the transaction. Verve Therapeutics, Inc. (Nasdaq:VERV) announced the expansion of its relationship with Eli Lilly...
Verve Therapeutics’ Relationship Expansion with Lilly
MapLight Therapeutics’ $225 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
Aqtual’s $16 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Aqtual on the transaction. Aqtual announced it has completed a $16 million Series A round of financing co-led by Genoa Ventures,...
Cloud Light Technology’s $750 Million Acquisition of Lumentum
Morgan, Lewis & Bockius is advising Cloud Light Technology Limited on the transaction, and Wilson Sonsini Goodrich & Rosati is advising Lumentum Holdings Inc. Hong Kong–based...
Evergrow’s Funding Clean Energy Tax Credit Transfers
Wilson Sonsini Goodrich & Rosati represented Evergrow in the transaction. Evergrow announced it has closed its clean energy tax credit transfer on its platform, one of the...
Warwick Carbon Solutions’ Industrial Decarbonization Project
Wilson Sonsini Goodrich & Rosati served as lead project development and finance counsel to Warwick Carbon Solutions in the transaction Warwick Carbon Solutions (WCS) subsidiary Broadwing...
DermBiont’s $35.2 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati provided IP and corporate counsel to DermBiont in the transaction. DermBiont announced its $35.2 million Series B financing. The financing was led...
Automattic’s $50 Million Acquisition of Texts.com
Wilson Sonsini Goodrich & Rosati represented Texts.com in the transaction. Automattic announced the acquisition of Texts.com for $50 million. The acquisition allows Automattic into a fourth market that’s integral...
Assembly Biosciences’ Partnership with Gilead Sciences
Wilson Sonsini Goodrich & Rosati advised Assembly Bio on the transaction, and Ropes & Gray advised Gilead Sciences, Inc. Assembly Biosciences (Nasdaq: ASMB) and Gilead Sciences (Nasdaq:...
Carlin Consumer Health’s Acquisition of Infirst USA Holdings
Sidley Austin LLP served as legal advisor to Carlin and Wilson Sonsini Goodrich Rosati acted as legal advisor to Infirst. Stifel acted as exclusive financial advisor...
Nexu’s $20 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised Valor Capital on the transaction. Nexu announced it has raised $20 million in a Series B funding. The round was led...
Tofu’s $5 Million Seed Financing Round
Wilson Sonsini Goodrich & Rosati advised Tofu on the transaction. Tofu announced that it raised $5 million in seed funding. The round was led by Index Ventures...